Yakai Fu

402 total citations
17 papers, 248 citations indexed

About

Yakai Fu is a scholar working on Epidemiology, Rheumatology and Hematology. According to data from OpenAlex, Yakai Fu has authored 17 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Rheumatology and 6 papers in Hematology. Recurrent topics in Yakai Fu's work include Inflammatory Myopathies and Dermatomyositis (7 papers), Eosinophilic Disorders and Syndromes (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Yakai Fu is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (7 papers), Eosinophilic Disorders and Syndromes (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Yakai Fu collaborates with scholars based in China, France and Israel. Yakai Fu's co-authors include Shuang Ye, Zhiwei Chen, Wanlong Wu, Kaiwen Wang, Wenwen Xu, Li Guo, Danting Zhang, Xiaodong Wang, Liyang Gu and Shuhui Sun and has published in prestigious journals such as Diabetes, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Yakai Fu

15 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yakai Fu China 8 145 113 66 62 52 17 248
Mirei Shirakashi Japan 9 124 0.9× 126 1.1× 79 1.2× 45 0.7× 63 1.2× 30 261
Jacqueline So China 9 131 0.9× 70 0.6× 25 0.4× 19 0.3× 53 1.0× 18 237
Youhei Fujiki Japan 11 143 1.0× 141 1.2× 129 2.0× 31 0.5× 51 1.0× 23 269
Ana D. Fernandes United States 9 67 0.5× 146 1.3× 86 1.3× 29 0.5× 40 0.8× 15 230
Jessica Neely United States 10 66 0.5× 61 0.5× 17 0.3× 26 0.4× 57 1.1× 15 206
Takahiro Nunokawa Japan 8 101 0.7× 85 0.8× 117 1.8× 15 0.2× 18 0.3× 24 218
Elizabeth Perry United Kingdom 7 45 0.3× 89 0.8× 117 1.8× 38 0.6× 67 1.3× 10 250
Katsuaki Asakawa Japan 7 151 1.0× 102 0.9× 134 2.0× 26 0.4× 28 0.5× 19 236
Víctor Martínez‐Taboada Spain 8 35 0.2× 120 1.1× 85 1.3× 18 0.3× 41 0.8× 8 195

Countries citing papers authored by Yakai Fu

Since Specialization
Citations

This map shows the geographic impact of Yakai Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yakai Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yakai Fu more than expected).

Fields of papers citing papers by Yakai Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yakai Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yakai Fu. The network helps show where Yakai Fu may publish in the future.

Co-authorship network of co-authors of Yakai Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yakai Fu. A scholar is included among the top collaborators of Yakai Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yakai Fu. Yakai Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Jingjing, Ran Wang, Jie Chen, et al.. (2025). Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome. Frontiers in Immunology. 16. 1604648–1604648.
2.
Fu, Yakai, Zhiwei Chen, Jie Chen, et al.. (2025). Efficacy of JAK inhibitor combined with protein A immunoadsorption in MDA5+ dermatomyositis with RPILD: A real-world study. Med. 6(10). 100802–100802. 1 indexed citations
3.
Lian, Xinyue, Chengqiang Xia, Zhiwei Chen, et al.. (2025). Muscle Visualization and Evaluation Methods for Immune Checkpoint Inhibitor-Related Myositis. Journal of Visualized Experiments.
4.
Fu, Yakai, Zhice Xu, Chunmei Wu, et al.. (2025). Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 84(11). 1811–1821. 1 indexed citations
5.
Fu, Yakai, Liyang Gu, Yuting Dai, et al.. (2024). Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody. RMD Open. 10(1). e003901–e003901. 8 indexed citations
6.
Wu, Wanlong, Runci Wang, Yi Chen, et al.. (2024). Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19. Frontiers in Immunology. 15. 1295472–1295472. 1 indexed citations
7.
Fu, Yakai, Zhiwen Chen, Fangfang Sun, et al.. (2024). Eculizumab Improves Renal Survival in Complement-Mediated TMA Secondary to SLE. Mayo Clinic Proceedings. 100(1). 164–167. 3 indexed citations
8.
Zhang, Le, Jun Li, Yuan Li, et al.. (2023). Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study. Annals of the Rheumatic Diseases. 82(5). 722–724. 18 indexed citations
9.
Fu, Yakai, Wanlong Wu, Zhiwei Chen, et al.. (2022). Trisomy 8 Associated Clonal Cytopenia Featured With Acquired Auto-Inflammation and Its Response to JAK Inhibitors. Frontiers in Medicine. 9. 895965–895965. 7 indexed citations
10.
11.
Fu, Yakai, Jia Li, Antao Xu, et al.. (2022). Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still’s disease with delayed hypersensitivity reaction to tocilizumab. Lara D. Veeken. 62(7). e223–e225. 7 indexed citations
12.
Fu, Yakai & Shuang Ye. (2021). A molecular signature as a guidance for glucocorticoid: are we there yet?. The Lancet Rheumatology. 3(5). e315–e317. 1 indexed citations
13.
Fu, Yakai, Yun Tan, Bo Wu, et al.. (2021). Gata2-L359V impairs primitive and definitive hematopoiesis and blocks cell differentiation in murine chronic myelogenous leukemia model. Cell Death and Disease. 12(6). 568–568. 9 indexed citations
14.
Wang, Kaiwen, Wanlong Wu, Wenwen Xu, et al.. (2021). RNA-Containing Immune Complexes Formed by Anti-Melanoma Differentiation Associated Gene 5 Autoantibody Are Potent Inducers of IFN-α. Frontiers in Immunology. 12. 743704–743704. 21 indexed citations
15.
Wu, Wanlong, Li Guo, Yakai Fu, et al.. (2021). Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clinical Reviews in Allergy & Immunology. 60(2). 293–304. 116 indexed citations
16.
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirei Shirakashi Breakdown of academic impact, for papers by Jacqueline So Breakdown of academic impact, for papers by Youhei Fujiki Breakdown of academic impact, for papers by Ana D. Fernandes Breakdown of academic impact, for papers by Jessica Neely Breakdown of academic impact, for papers by Takahiro Nunokawa Breakdown of academic impact, for papers by Elizabeth Perry Breakdown of academic impact, for papers by Katsuaki Asakawa Breakdown of academic impact, for papers by Víctor Martínez‐Taboada
Rankless by CCL
2026